ARS Pharmaceuticals, Inc.
Develops and commercializes needle-free products for administering therapies.
SPRY | US
Overview
Corporate Details
- ISIN(s):
- US82835W1080
- LEI:
- Country:
- United States of America
- Address:
- 11682 EL CAMINO REAL, SUITE 300, 92130 SAN DIEGO
- Website:
- https://ars-pharma.com/
- Sector:
- Manufacturing
Description
ARS Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative, needle-free products for administering therapies. The company's lead product is neffy (epinephrine nasal spray), the first and only FDA-approved needle-free treatment for severe allergic reactions (Type I hypersensitivity), including anaphylaxis. Developed as a patient-friendly alternative to auto-injectors, neffy is designed to be easy to carry and use, addressing challenges such as needle-related risks and hesitation in administration for both patients and caregivers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ARS Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ARS Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ARS Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
